These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30650541)

  • 21. Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties.
    Bigdeli A; Palchetti S; Pozzi D; Hormozi-Nezhad MR; Baldelli Bombelli F; Caracciolo G; Mahmoudi M
    ACS Nano; 2016 Mar; 10(3):3723-37. PubMed ID: 26882007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
    Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma.
    Deodhar S; Dash AK; North EJ; Hulce M
    AAPS PharmSciTech; 2020 Aug; 21(6):231. PubMed ID: 32778980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biomolecular corona of gold nanoparticles in a controlled microfluidic environment.
    Digiacomo L; Palchetti S; Giulimondi F; Pozzi D; Zenezini Chiozzi R; Capriotti AL; Laganà A; Caracciolo G
    Lab Chip; 2019 Aug; 19(15):2557-2567. PubMed ID: 31243412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer.
    Ndemazie NB; Bulusu R; Zhu XY; Frimpong EK; Inkoom A; Okoro J; Ebesoh D; Rogers S; Han B; Agyare E
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoliposomal irinotecan plus fluorouracil and folinic acid: a new treatment option in metastatic pancreatic cancer.
    Ur Rehman SS; Lim K; Wang-Gillam A
    Expert Rev Anticancer Ther; 2016 May; 16(5):485-92. PubMed ID: 27043737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive analysis of liposomal biomolecular corona upon human plasma incubation: The evolution towards the lipid corona.
    La Barbera G; Capriotti AL; Caracciolo G; Cavaliere C; Cerrato A; Montone CM; Piovesana S; Pozzi D; Quagliarini E; Laganà A
    Talanta; 2020 Mar; 209():120487. PubMed ID: 31892008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein Corona of Anionic Fluid-Phase Liposomes Compromises Their Integrity Rather than Uptake by Cells.
    Tretiakova D; Kobanenko M; Alekseeva A; Boldyrev I; Khaidukov S; Zgoda V; Tikhonova O; Vodovozova E; Onishchenko N
    Membranes (Basel); 2023 Jul; 13(7):. PubMed ID: 37505047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Development of a New Type of Hybrid PLGA/Lipid Nanoparticle as an Ursolic Acid Delivery System against Pancreatic Ductal Adenocarcinoma Cells.
    Markowski A; Jaromin A; Migdał P; Olczak E; Zygmunt A; Zaremba-Czogalla M; Pawlik K; Gubernator J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer.
    Madamsetty VS; Pal K; Dutta SK; Wang E; Mukhopadhyay D
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells.
    Pozzi D; Colapicchioni V; Caracciolo G; Piovesana S; Capriotti AL; Palchetti S; De Grossi S; Riccioli A; Amenitsch H; Laganà A
    Nanoscale; 2014 Mar; 6(5):2782-92. PubMed ID: 24463404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma.
    Lamb YN; Scott LJ
    Drugs; 2017 May; 77(7):785-792. PubMed ID: 28401446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.
    Caracciolo G
    Nanomedicine; 2015 Apr; 11(3):543-57. PubMed ID: 25555353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface chemistry and serum type both determine the nanoparticle-protein corona.
    Pozzi D; Caracciolo G; Capriotti AL; Cavaliere C; La Barbera G; Anchordoquy TJ; Laganà A
    J Proteomics; 2015 Apr; 119():209-17. PubMed ID: 25731725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy.
    Pardeshi S; Tiwari A; Titame U; Singh PK; Yadav PK; Chourasia MK
    J Liposome Res; 2022 Dec; 32(4):386-395. PubMed ID: 35225132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.